Table 3. PK, Cell Activity, and Kinase Selectivity of Selected Compounds.
Cpd | IRAK4 IC50 (nM) | Cell IC50a (nM) | Kinase Selectivityb | Pappc (×10–6 cm/s) | Solubilityd (μM) | Rat Cle (mL/min/kg) | Rat %Ff |
---|---|---|---|---|---|---|---|
12 | 18 | 78 | 96 | 12 | 26 | – | – |
13 | 67 | 292 | 96 | 18 | 23 | 75 | 4 |
16 | 27 | 141 | 99 | 5 | 12 | 88 | 0 |
18 | 11 | 375 | 94 | 7 | 63 | 98 | 0 |
19 | 19 | 187 | 90 | 29 | 21 | 45 | 13 |
26 | 85 | 333 | 96 | 9 | 8 | 43 | 2 |
31 | 93 | 580 | 97 | 15 | 13 | 51 | 42 |
See Supporting Information for assay protocol.
Percent kinases with >100-fold selectivity (n = 111) versus IRAK, IC50, see Supporting Information for additional details.
Measured in LLC-PK1 cells.
Measured kinetic solubility at pH 7.
IV dosed at 1 mg/kg as a solution of 1 mg/mL in 20% HPBCD.
PO dosed at 10 mg/kg as a suspension of 2 mg/mL in 0.4% methylcellulose. See Supporting Information for full PK parameters for compounds 19 and 31.